Assessing toxicities after CAR T cell infusion for lymphoma.
Study #: CT20-03b
Study Status: Published
Cytokine release syndrome and neurotoxicity following CD19 CAR-T in B-cell lymphoma.
Citation
Shouval R, Strouse C, Kim S, Oloyede T, Ahmed S, Awan FT, Luan D, Bachanova V, Badar T, Bar M, Barba P, Beintinjaneh AM, Cashen A, Dholaria B, Elsawy M, Ganguly S, Geethakumari PR, Greenbaum U, Hashmi H, Hill LC, Jain MD, Jain T, Kebriaei P, Kittai AS, Locke FL, Lulla PD, Mead E, McGuirk JP, Mussetti A, Nishihori T, Olson AL, Pennisi M, Perales MA, Riedell PA, Saber W, Mirza AS, Magalhaes-Silverman M, Shpall EJ, Sorror M, Wudhikarn K, Turtle CJ, Moskop A, Pasquini MC.
Transplantation and Cellular Therapy. 2025, Jul 01: 31(7): 31(7):419-433. doi: 10.1016/j.jtct.2025.03.011. Epub 2025, Apr 25. PMCID:PMC12622908.
PubMed
PMID: 40288610
Abstract
